ATE348183T1 - Zusammensetzungen und verfahren zur intraductalen gentherapie - Google Patents
Zusammensetzungen und verfahren zur intraductalen gentherapieInfo
- Publication number
- ATE348183T1 ATE348183T1 AT00914435T AT00914435T ATE348183T1 AT E348183 T1 ATE348183 T1 AT E348183T1 AT 00914435 T AT00914435 T AT 00914435T AT 00914435 T AT00914435 T AT 00914435T AT E348183 T1 ATE348183 T1 AT E348183T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- ductal
- cell
- intraductal
- compositions
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000001415 gene therapy Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 210000000481 breast Anatomy 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 210000000981 epithelium Anatomy 0.000 abstract 2
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 210000005075 mammary gland Anatomy 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000026683 transduction Effects 0.000 abstract 1
- 238000010361 transduction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
- C12N2810/6009—Vectors comprising as targeting moiety peptide derived from defined protein from viruses dsDNA viruses
- C12N2810/6018—Adenoviridae
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11647099P | 1999-01-20 | 1999-01-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE348183T1 true ATE348183T1 (de) | 2007-01-15 |
Family
ID=22367379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00914435T ATE348183T1 (de) | 1999-01-20 | 2000-01-20 | Zusammensetzungen und verfahren zur intraductalen gentherapie |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6514695B1 (de) |
| EP (1) | EP1147208B1 (de) |
| AT (1) | ATE348183T1 (de) |
| AU (1) | AU777130B2 (de) |
| CA (1) | CA2356960C (de) |
| DE (1) | DE60032333T2 (de) |
| ES (1) | ES2278596T3 (de) |
| IL (2) | IL143988A0 (de) |
| WO (1) | WO2000042972A2 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU769853B2 (en) * | 1999-06-11 | 2004-02-05 | Atossa Genetics, Inc. | Gel composition for filing a breast milk duct prior to surgical excision of the duct or other breast tissue |
| RU2290933C1 (ru) * | 2005-04-11 | 2007-01-10 | Ростовский научно-исследовательский онкологический институт МЗ РФ | Способ лечения рака |
| US9332973B2 (en) | 2008-10-01 | 2016-05-10 | Covidien Lp | Needle biopsy device with exchangeable needle and integrated needle protection |
| US9186128B2 (en) * | 2008-10-01 | 2015-11-17 | Covidien Lp | Needle biopsy device |
| US11298113B2 (en) | 2008-10-01 | 2022-04-12 | Covidien Lp | Device for needle biopsy with integrated needle protection |
| US9782565B2 (en) | 2008-10-01 | 2017-10-10 | Covidien Lp | Endoscopic ultrasound-guided biliary access system |
| US8968210B2 (en) | 2008-10-01 | 2015-03-03 | Covidien LLP | Device for needle biopsy with integrated needle protection |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5763415A (en) * | 1995-08-03 | 1998-06-09 | John Hopkins University School Of Medicine | Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer |
-
2000
- 2000-01-20 WO PCT/US2000/001397 patent/WO2000042972A2/en not_active Ceased
- 2000-01-20 AT AT00914435T patent/ATE348183T1/de not_active IP Right Cessation
- 2000-01-20 CA CA002356960A patent/CA2356960C/en not_active Expired - Fee Related
- 2000-01-20 ES ES00914435T patent/ES2278596T3/es not_active Expired - Lifetime
- 2000-01-20 EP EP00914435A patent/EP1147208B1/de not_active Expired - Lifetime
- 2000-01-20 US US09/488,464 patent/US6514695B1/en not_active Expired - Lifetime
- 2000-01-20 DE DE60032333T patent/DE60032333T2/de not_active Expired - Lifetime
- 2000-01-20 AU AU35827/00A patent/AU777130B2/en not_active Ceased
- 2000-01-20 IL IL143988A patent/IL143988A0/xx unknown
-
2001
- 2001-06-25 IL IL143988A patent/IL143988A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1147208A2 (de) | 2001-10-24 |
| IL143988A0 (en) | 2002-04-21 |
| WO2000042972A2 (en) | 2000-07-27 |
| IL143988A (en) | 2009-11-18 |
| DE60032333D1 (de) | 2007-01-25 |
| EP1147208B1 (de) | 2006-12-13 |
| DE60032333T2 (de) | 2007-06-21 |
| CA2356960C (en) | 2009-10-06 |
| WO2000042972A3 (en) | 2000-09-28 |
| ES2278596T3 (es) | 2007-08-16 |
| AU3582700A (en) | 2000-08-07 |
| EP1147208A4 (de) | 2002-10-02 |
| AU777130B2 (en) | 2004-10-07 |
| US6514695B1 (en) | 2003-02-04 |
| CA2356960A1 (en) | 2000-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN05300A1 (en) | Treatment with anti-vegf antibodies | |
| WO2003004989A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| DE60229727D1 (de) | Methylation-modulierende verbingungen zur intraduktalen behandlung von brustkrebs | |
| PT1472541E (pt) | Agentes de imagiologia e métodos de imagiologia de naaladase de psma | |
| IL140700A0 (en) | Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids | |
| WO2004113571A3 (en) | Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis | |
| MXPA02011656A (es) | Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos. | |
| BR0209646A (pt) | genes expressos em cáncer de mama como alvos de prognósticos e terapêuticos | |
| ATE419516T1 (de) | Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc) | |
| YU37304A (sh) | Specifični agensi koji vezuju humani angiopoetin-2 | |
| WO2003087831A3 (en) | Proteins involved in breast cancer | |
| WO2003000012A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer | |
| EA200800268A1 (ru) | КОМБИНИРОВАННАЯ ТЕРАПИЯ АНТИТЕЛОМ ПРОТИВ CTLA-4 И СОДЕРЖАЩИМ CpG-МОТИВ СИНТЕТИЧЕСКИМ ОЛИГОДЕЗОКСИНУКЛЕОТИДОМ ДЛЯ ЛЕЧЕНИЯ ЗЛОКАЧЕСТВЕННОЙ ОПУХОЛИ | |
| ATE501722T1 (de) | Therapeutische behandlung androgenrezeptorbedingter leiden | |
| WO2004106495A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| WO2000055629A3 (en) | Methods of diagnosing and treating breast cancer | |
| ATE526037T1 (de) | Verfahren zum abtöten von tumorzellen mittels targeting von auf apoptotischen tumorzellen exponierten internen antigenen | |
| BR9807418A (pt) | Terapia de gene supressor de tumor combinado e quimioterapia no tratamento de neoplasmas | |
| BR9808509A (pt) | Composições e métodos para o tratamento e diagnóstico do câncer de mama | |
| AU3392901A (en) | Proteins | |
| ATE318328T1 (de) | Diagnostika und therapeutika für osteoporose | |
| ATE348183T1 (de) | Zusammensetzungen und verfahren zur intraductalen gentherapie | |
| WO2001071357A3 (en) | Diagnosis and treatment of breast cancer | |
| MXPA05007940A (es) | Composiciones y metodos para el tratamiento del cancer usando igsf9 y liv-1. | |
| GB0004576D0 (en) | Proteins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |